Fundraising FoxVesper Medical
Wayne, US · Founded 2016 · Delaware corporation · 5 known investors
Find your way into Vesper Medical
Sign up to see every warm intro you have to Vesper Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vesper Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease. The devices are intended for physicians treating patients with deep venous disease, positioning the company in the vascular medical device space.
Founders & leadership
BJ
Bruce J. ShookPresident and CEO
MK
Monica KlosController & Treasurer2016–2022Monica Klos brings more than 30 years of accounting and finance experience, including work at Big Four firms and roles in both public and private companies. At Vesper Medical, she oversees corporate accounting, financial reporting, budgeting, and risk management.
PS
Peter SchneiderNamed on SEC filing
MG
Mark GarciaNamed on SEC filing
DW
Dennis W. WahrNamed on SEC filing
Board
PS
P. Sherrill NeffBoard director
JK
Investors · 5
New Enterprise Associates (NEA)✓ confirmed by Vesper MedicalMenlo Park · $200K – $40M
How we know: the company's own site · Not right? Tell us
Gilde Healthcare✓ confirmed by Vesper MedicalUtrecht · $1.1M – $55M
How we know: the company's own site · funding news · Not right? Tell us
Lightstone Ventures✓ confirmed by Vesper MedicalPortola Valley
How we know: the company's own site · Not right? Tell us
Vensana Capital✓ confirmed by Vesper MedicalMinneapolis
How we know: the company's own site · funding news · the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements$22.5M disclosed across 2 of 3 rounds · 2016–2019
- Undisclosed amountSeries AMay 2018 · 2 sourcesSource ↗
▶$7MraisedJun 2019 · 30 investors · Other Health CareRule 506(b)
▶$7MraisedJun 2019 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bruce J. ShookExecutive Officer, Director
- Mark GarciaDirector
- Neil HattangadiDirector
- P. Sherill NeffDirector
- Peter SchneiderDirector
- Marc PennaExecutive Officer
- Josh MakowerDirector
- Monica KlosExecutive Officer
- Joseph C. Griffin, IIIExecutive Officer
- Michael LongoExecutive Officer
- Howard RosenExecutive Officer
- Dennis W. WahrDirector
- Offering amount
- $37.2M
- Amount sold
- $7M
- Proceeds to insiders
- $9M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$15.5MraisedMay 2018 · 37 investors · Other Health CareRule 506(b)
▶$15.5MraisedMay 2018 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- P. Sherrill NeffDirector
- Neil HattangadiDirector
- Peter SchneiderDirector
- Mark GarciaDirector
- Justin KleinDirector
- Bruce J. ShookExecutive Officer, Director
- Monica KlosExecutive Officer
- Dennis W. WahrDirector
- Offering amount
- $15.5M
- Amount sold
- $15.5M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Verse MedicalVerse Medical builds software to coordinate home-based healthcare services, replacing fragmented vendor interactions and outdated communication methods with a unified platform for in-home care providers.
CqmedicalCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Vantis VascularVantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter>
<parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter>
<parameter name="hq_city">San Jose
Companies working in the same space as Vesper Medical.
In the news
Frequently asked questions
- What does Vesper Medical do?
- Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease. The devices are intended for physicians treating patients with deep venous disease, positioning the company in the vascular medical device space.
- Who are Vesper Medical's investors?
- Vesper Medical's investors include New Enterprise Associates (NEA), Gilde Healthcare, Lightstone Ventures, Vensana Capital, 415 Capital.
- How much funding has Vesper Medical raised?
- Vesper Medical has disclosed $22.5M raised across 2 of its 3 known rounds.
- Where is Vesper Medical headquartered?
- Vesper Medical is headquartered in Wayne, US.